# Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients

> **NCT00586716** · NA · TERMINATED · sponsor: **Loma Linda University** · enrollment: 22 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** intravenous immune globulin

## Key facts

- **NCT ID:** NCT00586716
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** 2009-09
- **Final completion:** 2009-10
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2017-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00586716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00586716, "Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00586716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*